How to Help Your Patients Find Monovisc in Stock: A Provider's Guide

Prescribing Monovisc is only half the battle. For many patients with knee osteoarthritis, the administrative and logistical hurdles between prescription and injection can be substantial — and often fall to your practice to navigate. This guide provides practical, workflow-oriented guidance for orthopedic surgeons, rheumatologists, sports medicine specialists, and their office staff to ensure patients can actually receive the Monovisc treatment they've been prescribed.

Step 1: Verify Insurance Coverage Before Ordering

The most common cause of delays in viscosupplement treatment is scheduling an injection before insurance has been verified. Make insurance verification a mandatory first step in your Monovisc workflow:

Confirm the patient's insurance type (Medicare Part B, commercial, Medicaid)

Confirm that Monovisc (J7327) is covered under the patient's specific plan

Determine whether prior authorization is required and initiate it the same day as the prescription

For Aetna and BCBS patients: determine whether step therapy is required before Monovisc will be covered, or if a medical necessity exception can bypass it

Confirm frequency limits — most plans allow repeat treatment every 6 months per knee

Step 2: Build a Complete Prior Authorization Package Upfront

Incomplete prior authorization submissions are the most common cause of delays and initial denials. Build a complete package the first time:

Diagnosis: ICD-10 M17.x with clinical examination findings documenting knee OA severity and functional impact

Imaging: X-ray within 12 months showing OA (joint space narrowing, osteophytes); most commercial MACs and payers require recent imaging

Conservative treatment failure: Chart documentation showing ≥3–6 months of physical therapy, NSAID or analgesic use, and/or activity modification with inadequate pain relief

Letter of medical necessity: For non-preferred status insurers, provide a letter explaining why Monovisc specifically is preferred — for example: non-avian formulation for a patient with avian sensitivity; maximum-dose single injection minimizing appointment burden for a patient with transportation limitations; or prior treatment success with this specific product

J-code: J7327 for Monovisc; ensure this is correctly documented in the PA submission

Step 3: Ensure Your Practice Stocks Monovisc (or Has a Reliable Ordering Pathway)

If your practice prescribes Monovisc regularly, maintaining a stocking arrangement with your specialty distributor is the most efficient approach. Monovisc should be stored at controlled room temperature (2–25°C / 36–77°F) and protected from freezing. Each pre-filled syringe is single-use only.

If your practice does not stock Monovisc as a routine item, establish a clear ordering workflow for cases when it is specifically requested:

Contact your DePuy Synthes representative or preferred specialty distributor to confirm current lead times

Do not schedule the patient's injection appointment until the product has been ordered and is confirmed for delivery

Build at least 5–7 business days between ordering and the injection appointment to account for delivery and PA resolution simultaneously

Step 4: Counsel Patients on What to Expect

Setting clear expectations before the injection reduces patient anxiety and follow-up calls. Key counseling points for Monovisc patients:

Pain relief may not be immediate — some patients notice improvement within 2–4 weeks, and maximum benefit may take 4–8 weeks

Mild injection site pain, swelling, and warmth for 1–3 days post-injection is normal and expected

Patients should avoid strenuous activity, jogging, high-impact sports, or prolonged weight-bearing (>1 hour) for 48 hours post-injection

Patients should call your office immediately for fever, chills, severe swelling, or signs of infection — these are rare but serious

If meaningful relief is achieved, the injection can typically be repeated every 6 months

Step 5: Direct Patients to medfinder for Help Finding Access

For patients who need to find a Monovisc-stocking provider — whether because your practice doesn't carry it, they need a second location, or they're traveling — medfinder for providers is a service that contacts providers near your patient to find out who has Monovisc in stock and can fill their prescription. You can recommend medfinder directly to patients and even incorporate it into your practice's referral workflow.

When to Pivot to an Alternative Viscosupplement

If a patient's insurer denies Monovisc after an appeal, or if access barriers are unlikely to be resolved in a timely manner, consider pivoting to a covered preferred alternative. Synvisc-One and Durolane are the most commonly preferred single-injection alternatives for commercial payers. Euflexxa offers excellent multi-injection coverage for cost-sensitive patients. See our clinical guide to Monovisc alternatives for a full comparison.